| Revenue | 31/12/2018 | 31/12/2017 | 31/12/2016 | 31/12/2015 |
| Total revenue | 907,208 | 861,390 | 741,420 | 764,717 |
| Cost of revenue | 304,631 | 258,971 | 238,546 | 234,919 |
| Gross profit | 602,577 | 602,419 | 502,874 | 529,798 |
| Operating expenses |
| Research development | 264,727 | 254,565 | 329,576 | 341,750 |
| Selling general and administrative | 322,880 | 307,946 | 274,332 | 291,523 |
| Non-recurring | - | - | - | - |
| Others | - | - | - | - |
| Total operating expenses | 892,238 | 821,482 | 842,454 | 868,192 |
| Operating income or loss | 14,970 | 39,908 | -101,034 | -103,475 |
| Income from continuing operations |
| Total other income/expenses net | 11,493 | -2,325 | -3,697 | -26,707 |
| Earnings before interest and taxes | 14,970 | 39,908 | -101,034 | -103,475 |
| Interest expense | - | - | - | - |
| Income before tax | 26,463 | 37,583 | -104,731 | -130,182 |
| Income tax expense | 11,006 | 10,944 | 3,442 | -8,672 |
| Minority interest | - | - | - | - |
| Net income from continuing ops | 15,457 | 26,639 | -108,173 | -121,510 |
| Non-recurring events |
| Discontinued operations | - | - | - | - |
| Extraordinary items | - | - | - | - |
| Effect of accounting changes | - | - | - | - |
| Other items | - | - | - | - |
| Net income |
| Net income | 15,457 | 26,639 | -108,173 | -121,510 |
| Preferred stock and other adjustments | - | - | - | - |
| Net income applicable to common shares | 15,457 | 26,628 | -108,173 | -121,510 |